20-Dec-2024
J.P. Morgan’s top Healthcare stocks for 2025
Seeking Alpha News (Fri, 20-Dec 11:30 AM ET)
Benzinga (Thu, 19-Dec 1:38 PM ET)
J.P. Morgan Sticks to Their Buy Rating for Healthequity (HQY)
TipRanks (Wed, 18-Dec 7:05 AM ET)
HealthEquity Caps 2024 With Widespread Recognition For Its Workplace Excellence
Globe Newswire (Tue, 17-Dec 9:20 AM ET)
HealthEquity Reports Third Quarter Ended October 31, 2024 Financial Results
Globe Newswire (Mon, 9-Dec 4:01 PM ET)
Globe Newswire (Tue, 3-Dec 9:20 AM ET)
HealthEquity CMO Tia Padia Named "Visionary CMO" at MarCom Awards
Globe Newswire (Tue, 19-Nov 9:20 AM ET)
HealthEquity Announces Retirement of CEO Jon Kessler; Scott Cutler Appointed Successor
Globe Newswire (Tue, 12-Nov 4:00 PM ET)
HealthEquity Announces Third Quarter Earnings Release Date
Globe Newswire (Wed, 30-Oct 4:01 PM ET)
HealthEquity receives two top honors at the 19th Annual Golden Globee Awards for Technology
Globe Newswire (Thu, 24-Oct 9:20 AM ET)
HealthEquity Inc provides solutions that allow consumers to make healthcare saving and spending decisions. It provides payment processing services, personalized benefit information, the ability to earn wellness incentives, and investment advice to grow their tax-advantaged healthcare savings. It manages consumers' tax-advantaged health savings accounts (HSAs) and other consumer-directed benefits (CDBs) offered by employers, including flexible spending accounts and health reimbursement arrangements (FSAs and HRAs), and administers Consolidated Omnibus Budget Reconciliation Act (COBRA), commuter and other benefits. It also provides investment advisory services to customers whose account balances exceed a certain threshold. HealthEquity generates its revenue in the United States.
Healthequity trades on the NASDAQ stock market under the symbol HQY.
As of December 20, 2024, HQY stock price climbed to $94.95 with 1,484,109 million shares trading.
HQY has a beta of 0.81, meaning it tends to be less sensitive to market movements. HQY has a correlation of 0.10 to the broad based SPY ETF.
HQY has a market cap of $8.26 billion. This is considered a Mid Cap stock.
Last quarter Healthequity reported $300 million in Revenue and $.78 earnings per share. This beat revenue expectation by $10 million and exceeded earnings estimates by $.06.
In the last 3 years, HQY traded as high as $105.82 and as low as $39.73.
The top ETF exchange traded funds that HQY belongs to (by Net Assets): IJH, VTI, IWM, VB, VXF.
HQY has outperformed the market in the last year with a return of +47.1%, while the SPY ETF gained +27.8%. In the last 3 month period, HQY beat the market returning +19.4%, while SPY returned +4.4%. However, in the most recent 2 weeks HQY has underperformed the stock market by returning -5.2%, while SPY returned -2.4%.
HQY support price is $92.91 and resistance is $96.62 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that HQY shares will trade within this expected range on the day.